Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use… recall
FDA recall D-0713-2026 · initiated Jul 15, 2026
Asclemed USA Inc. recalled Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose,… in Jul 2026 — an FDA Class III recall (D-0713-2026) because Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan.
Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why it was recalled
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Labelling, packaging or a product mix-up
The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 18 kits
Details
- Product
- Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
- Recalling company
- Asclemed USA Inc.
- Classification
- Class III
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Within U.S. - Tennessee
- Initiated
- Jul 15, 2026
- FDA report date
- Jul 29, 2026
Frequently asked
- Was Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose,… recalled?
- Asclemed USA Inc. recalled Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose,… in Jul 2026 — an FDA Class III recall (D-0713-2026) because Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
- Why was Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose,… recalled?
- Per the FDA enforcement record, the reason for recall D-0713-2026 was: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
- Is a recalled Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose,… dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose,… are affected?
- Distributed: Within U.S. - Tennessee. The recall covers these lots — Lot: 070126X1, Exp. 12/31/2027.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0713-2026.